← back to search

Christopher G. Dove

California Institute for Regenerative Medicine ·
Area of research
Biotechnology · Genetics
Research interest
Research interests include Biology, Reversion, Immunodeficiency, Germline mutation, Somatic cell, and SIGLEC.
h-index
citations
142
works
2
NIH funding
primary concept
email

Recent publications

MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
Proceedings of the National Academy of Sciences 2023cited by 63position: middledoi
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype
Journal of Allergy and Clinical Immunology 2014cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

T. Prescott Atkinson · University of Alabama at Birmingham1 papers (2014–2014)Carolyn R. Bertozzi · Stanford University1 papers (2023–2023)Yu Zhang · Kunming University of Science and Technology1 papers (2014–2014)Ashish Kumar · Medical College of Wisconsin1 papers (2014–2014)Benjamin Smith · University of Kentucky1 papers (2023–2023)David B. Lewis · ENT and Allergy1 papers (2014–2014)Srividya Swaminathan · City Of Hope National Medical Center1 papers (2023–2023)Helen Matthews · Parkinson's UK1 papers (2014–2014)Jessica C. Stark · Massachusetts Institute of Technology1 papers (2023–2023)Nicholas M. Riley · University of Washington1 papers (2023–2023)John V. Pluvinage · Arc Research Institute1 papers (2023–2023)Gülbû Uzel · National Institutes of Health1 papers (2014–2014)Dean W. Felsher · Stanford Health Care1 papers (2023–2023)Peter Mustillo · The Ohio State University1 papers (2014–2014)Helen C. Su · ActionAid1 papers (2014–2014) · 1 papers (2023–2023)Erwin W. Gelfand · University of Colorado Denver1 papers (2014–2014)Huie Jing · National Institute of Allergy and Infectious Diseases1 papers (2014–2014)Daniel C. Douek · Institut de Recherche Vaccinale1 papers (2014–2014)Anand Rajan · Rutgers, The State University of New Jersey1 papers (2023–2023)